Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

Yes, Obijankenobi, I find the straightforward sty

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72447
Posted On: 04/05/2013 5:00:33 AM
Posted By: alj14
Re: obijankenobi #8466

Yes, Obijankenobi,


I find the straightforward style of that paragraph very indicative of the probably decisive importance of Kevetrin to the future of treating various kinds of cancer:


"Cancer treatment may get customizable. We may be getting closer than ever to winning the war on cancer, because researchers have come up with a single drug that can treat many different kinds of cancers, such as melanoma, breast cancer, and leukemia. Drugs such as Kevetrin, now in Phase I clinical trials at Harvard University’s Dana-Farber Cancer Institute, work with the body’s natural defense system to target what’s known as the “guardian angel gene” (a.k.a. the p53 protein) to program it to either fix a cancerous cell or make it to self-destruct. If FDA-approved, this customizable cancer drug could especially benefit those with rare types of the disease that don’t get much funding."


**************


The message couldn't come through much stronger than that. Just looking at another prominent biotech that had news yesterday, In Vivo (NVIV), any material event is likely to produce a quick response in the SP. My guiding principle in this case is that it's more a matter of "when", rather than a matter of "if", because all the preliminary indications with Kevetrin (and with Prurisol, too) have reinforced expectations. Naturally, definitive news is what we are waiting for, and that too will come step by step, but we are getting closer.




(0)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us